Coactivation d’AMPK et de mTORC1

Author： Tamburini Jérôme   Poulain Laury   Bouscary Didier   Sujobert Pierre  

Publisher： Edp Sciences

E-ISSN： 1958-5381|31|10|836-839

ISSN： 0767-0974

Source： Médecine/sciences, Vol.31, Iss.10, 2015-10, pp. : 836-839

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

mTORC1 et sirolimus

By Tartarin Pauline   Froment Pascal  

Médecine/sciences, Vol. 29, Iss. 2, 2013-02 ,pp. : 200-205

Edp Sciences

Access to resources Recommend Favorite

mTORC1 and the regulation of skeletal muscle anabolism and mass

By Adegoke Olasunkanmi A.J.   Abdullahi Abdikarim   Tavajohi-Fini Pegah  

Applied Physiology, Nutrition, and Metabolism, Vol. 37, Iss. 3, 2012-06 ,pp. : 395-406

NRC Research Press

Access to resources Recommend Favorite

O‐18: mTORC1 is a novel HCV host factor

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 11-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanced solid tumors or multiple myeloma

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3481-3490

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon-γ Inhibits Nonopsonized Phagocytosis of Macrophages via an mTORC1-c/EBPβ Pathway

By  

Journal of Innate Immunity, Vol. 7, Iss. 2, 2014-09 ,pp. : 165-176

Karger

Access to resources Recommend Favorite